Sermorelin was once an approved drug and now shows up two very different ways, so here is how to tell which one a listing is selling.
Type where to buy sermorelin into a search bar and you get two kinds of results mixed together, and the page rarely tells you which one you landed on. One is a prescription product dispensed by a pharmacy. The other is a research-use vial sold by a peptide supplier for laboratory use, not for a person to inject on the strength of a website's suggested schedule. Sermorelin itself is a 29 amino acid analog of growth hormone releasing hormone (GHRH), the natural signal that tells the pituitary gland to release growth hormone. That single fact explains most of what follows: it is old, well characterized chemistry, not a new discovery, which is exactly why it is easy to manufacture and easy to sell under either label. This guide covers the research-use sourcing side, not medical use, dosing, or treatment advice. That distinction matters because a lot of sermorelin marketing blurs it on purpose, borrowing language from the compound's history as an approved drug to make a research-use vial sound like a medical product with a doctor and a diagnosis behind it. It usually is not, and the rest of this page is about telling the difference before you look at a specific listing.
Sermorelin acetate was sold under the brand name Geref by EMD Serono. The FDA approved the 0.05 mg ampule formulation in December 1990 and the 0.5 mg and 1.0 mg vial formulations in September 1997, for diagnosing and treating growth hormone deficiency in children. NCATS Inxight Drugs also lists Geref as having held orphan drug status, a designation reserved for treatments aimed at small patient populations. That approval history is real, and some sellers lean on it hard, describing sermorelin as an FDA-approved compound in the present tense as if the branded drug were still on shelves. It is also history, not current status. EMD Serono notified the FDA in 2008 that it was discontinuing Geref, and the FDA formally withdrew approval effective June 2009, later confirming that the withdrawal was not for reasons of safety or effectiveness, meaning it was a business decision, not a recall or a safety failure. NCATS Inxight Drugs, the NIH's drug-tracking database, now lists sermorelin acetate's US status as previously marketed rather than currently approved. A seller can accurately say sermorelin was FDA-approved. Saying it is FDA-approved, present tense, for a vial being sold today is a different and inaccurate claim, and it is worth reading a product page closely enough to notice which tense it actually uses.
Route one is a compounding pharmacy filling an individual prescription. That is a regulated, doctor-and-pharmacist process built around a specific patient, a specific prescriber, and a specific pharmacy's compounding license, and it sits outside what this guide reviews because it is not research-use sourcing. If a page is offering to sell a compounded prescription product without ever asking about a prescription, that is a sign the label does not match the actual process. Route two is a research supplier selling sermorelin as a raw material, typically as a lyophilized, or freeze-dried, powder in a sealed vial, intended for laboratory and research use only. Nothing about that category involves a prescriber, a pharmacy, or a patient file, and a listing that tries to have it both ways, research-use disclaimers alongside dosing charts aimed at a person, is describing two incompatible things on the same page. Approval and prescription rules for sermorelin are not the same everywhere, and we have not verified them market by market, so treat any specific legal claim about your own country with caution and check it locally rather than trusting a supplier's disclaimer page to get it right. A disclaimer is not a legal opinion, and a page that relies on one to justify dosing instructions is asking you to take on legal and safety judgment it has not actually done.
A listing that takes research use seriously shows you the compound identity and the batch, not just a product photo. That means a certificate of analysis, or COA, tied to the specific lot you are buying, ideally from an independent lab rather than the seller's in-house results. Our guide on what a COA is and our guide to reading a Janoshik-style report both walk through what the numbers on that document actually mean, including how to match a lot number on a vial to the lot number on the paperwork. Purity and identity are two separate checks. A COA should confirm both: that the vial contains sermorelin and roughly nothing else, which is purity, and that the peptide sequence matches sermorelin rather than something structurally close to it, which is identity. A single purity percentage with no identity data is half a quality check, since a very pure sample of the wrong peptide is still the wrong peptide. A seller who can produce this kind of documentation without being asked twice is telling you something about how the rest of their operation is run. A seller who treats a request for a batch-specific COA as an unusual or suspicious question is telling you something too.
Watch for language borrowed from the drug's old approved use and dressed up as a benefit for adults, since sermorelin was approved for pediatric growth hormone deficiency, not for adult outcomes, and a research-use seller repeating that framing is stretching an old pediatric indication into a claim it was never meant to support. Watch for pre-mixed, ready-to-inject pens marketed with a suggested schedule, since a research supplier sells raw material, not a finished dosing device meant for use on a person. Watch for a page with no lab name, no batch number, and no downloadable COA anywhere, only a generic purity claim in the product description. That pattern shows up across categories, not just sermorelin, and it is one of the checks in our guide to verifying a peptide supplier. Watch, too, for pricing that sits far below every other listed supplier for what is supposedly the same compound and the same purity, since synthesis, testing, and shipping all cost roughly the same regardless of which vendor's name is on the label, and a price that ignores that is usually cutting a corner somewhere in the chain. None of these signs alone proves a listing is bad. Together, two or three of them on the same page is a reasonable basis to look elsewhere.
Peptide Supplier Guide is run by the same team behind Peptide+, a supplier listed on this site, so we are not an independent third party and we do not pretend to be. What we do is score every listed supplier against the same criteria: lab testing practices, verified customer reviews, delivery reliability, guidance quality, and pricing, published on our how we rank page. We do not name a single best supplier for sermorelin or any other compound, and we do not attribute quotes or claims to any specific supplier on this page. What we can do is point you to the suppliers that have been scored on this guide, and to the location pages that cover where those suppliers operate, so the comparison is between documented criteria rather than between marketing pages that all read roughly the same.
Where a supplier is based changes what verification looks like in practice, since delivery speed, customs handling, and local reputation all vary by market. A supplier shipping domestically within a single country faces different customs exposure than one shipping across borders, and local reviews carry more weight when the reviewer base actually overlaps with your own situation. Our location pages break suppliers down by city rather than treating the research peptide market as one undifferentiated global marketplace, because it is not one. A supplier that scores well for delivery reliability in one region is not automatically making the same promise somewhere else. If you already know which market you are buying in, start there instead of a generic search. If you do not, our full list of scored suppliers is the faster starting point, followed by the verification checklist above before you send any payment to a listing you have not checked yet.
Research-use information only. Not medical advice.